Exploratory Study of Pagoclone in Men With Premature Ejaculation.
NCT00370981 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2013-12-27
Summary
The purpose of this study is to evaluate pagoclone in the treatment of premature ejaculation.
Conditions
- Premature Ejaculation
Interventions
- DRUG
-
pagoclone
Sponsors & Collaborators
-
Endo Pharmaceuticals
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2006-07-31
- Completion
- 2006-10-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
NCT00556478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
NCT02232425 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00229073 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.
NCT04062357 ·Status: COMPLETED ·Phase: PHASE2
-
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
NCT03055806 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00210704 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
NCT01021553 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00211094 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.
NCT04703127 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects
NCT01104948 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation
NCT02241460 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
NCT00211107 ·Status: COMPLETED ·Phase: PHASE3
-
A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation
NCT00537459 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation
NCT00210678 ·Status: COMPLETED
-
An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride
NCT01021670 ·Status: COMPLETED
-
Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
NCT01063855 ·Status: COMPLETED ·Phase: PHASE3
-
Proof of Mechanism in ELT
NCT00861484 ·Status: COMPLETED ·Phase: PHASE1
-
Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response
NCT03767452 ·Status: UNKNOWN ·Phase: PHASE4
-
Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction
NCT04361305 ·Status: UNKNOWN ·Phase: PHASE3
-
Trial of PED-1 in Male Patients With Premature Ejaculation
NCT01439984 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation
NCT01203202 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044
NCT01419470 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial
NCT07067970 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
NCT00210613 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
NCT00983151 ·Status: TERMINATED ·Phase: PHASE3